Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL8326 and Toripalimab in Advanced Solid Tumors
NCT07392736Phase 2Recruiting
- Sponsor
- Advenchen Laboratories
- Start
- Oct 2021
- Primary completion
- Nov 2029
- Countries
- 1
01
Overview
A Phase 2 trial of AL8326 in solid tumor, sponsored by Advenchen Laboratories. Started Oct 2021; status: recruiting.
02
Drugs
AL8326
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07392736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07392736.